[{"id":"6dd3ce99-ffa6-4279-8a8a-f2803ea9c91a","acronym":"","url":"https://clinicaltrials.gov/study/NCT02184897","created_at":"2021-01-18T10:11:38.740Z","updated_at":"2024-07-02T16:37:30.256Z","phase":"","brief_title":"Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization","source_id_and_acronym":"NCT02184897","lead_sponsor":"Asan Medical Center","biomarkers":" CD34","pipe":"","alterations":" ","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Granocyte (lenograstim)"],"overall_status":"Unknown status","enrollment":" Enrollment 24","initiation":"Initiation: 07/01/2014","start_date":" 07/01/2014","primary_txt":" Primary completion: 08/01/2016","primary_completion_date":" 08/01/2016","study_txt":" Completion: 12/01/2016","study_completion_date":" 12/01/2016","last_update_posted":"2016-07-26"}]